drugset / Trial / NCT00248456

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris

NCT00248456

Phase 4 Completed 320 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of calcipotriol plus betamethasone dipropionate ointment compared with calcipotriol ointment in the treatment of patients with psoriasis vulgaris for a duration of 4 weeks. The study will focus on the percentage change of the psoriasis area and severity index (PASI) from baseline to the end of week 4.

Timeline

Start
2005-10
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule
Subject betamethasone dipropionate Small molecule

Indications